Weiss T - Search Results

1

Leptomeningeal metastatic disease: new frontiers and future directions.

Ozair A, Wilding H, Bhanja D, Mikolajewicz N, Glantz M, Grossman SA, Sahgal A, Le Rhun E, Weller M, Weiss T, Batchelor TT, Wen PY, Haas-Kogan DA, Khasraw M, Rudà R, Soffietti R, Vollmuth P, Subbiah V, Bettegowda C, Pham LC, Woodworth GF, Ahluwalia MS, Mansouri A. Ozair A, et al. Among authors: weiss t. Nat Rev Clin Oncol. 2024 Dec 9. doi: 10.1038/s41571-024-00970-3. Online ahead of print. Nat Rev Clin Oncol. 2024. PMID: 39653782 Review.

2

Addition of lomustine for bevacizumab-refractory recurrent glioblastoma.

Tonder M, Eisele G, Weiss T, Hofer S, Seystahl K, Valavanis A, Stupp R, Weller M, Roth P. Tonder M, et al. Among authors: weiss t. Acta Oncol. 2014 Oct;53(10):1436-40. doi: 10.3109/0284186X.2014.920960. Epub 2014 May 26. Acta Oncol. 2014. PMID: 24862539 Free article. No abstract available.

3

Immunotherapy for glioblastoma: concepts and challenges.

Weiss T, Weller M, Roth P. Weiss T, et al. Curr Opin Neurol. 2015 Dec;28(6):639-46. doi: 10.1097/WCO.0000000000000249. Curr Opin Neurol. 2015. PMID: 26402401 Free article. Review.

4

Immunological effects of chemotherapy and radiotherapy against brain tumors.

Weiss T, Weller M, Roth P. Weiss T, et al. Expert Rev Anticancer Ther. 2016 Oct;16(10):1087-94. doi: 10.1080/14737140.2016.1229600. Epub 2016 Sep 6. Expert Rev Anticancer Ther. 2016. PMID: 27598516 Free article. Review.

5

NKG2D-Dependent Antitumor Effects of Chemotherapy and Radiotherapy against Glioblastoma.

Weiss T, Schneider H, Silginer M, Steinle A, Pruschy M, Polić B, Weller M, Roth P. Weiss T, et al. Clin Cancer Res. 2018 Feb 15;24(4):882-895. doi: 10.1158/1078-0432.CCR-17-1766. Epub 2017 Nov 21. Clin Cancer Res. 2018. PMID: 29162646 Free article.

6

NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma.

Weiss T, Weller M, Guckenberger M, Sentman CL, Roth P. Weiss T, et al. Cancer Res. 2018 Feb 15;78(4):1031-1043. doi: 10.1158/0008-5472.CAN-17-1788. Epub 2017 Dec 8. Cancer Res. 2018. PMID: 29222400 Free article.

7

Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.

Papa E, Weller M, Weiss T, Ventura E, Burghardt I, Szabó E. Papa E, et al. Among authors: weiss t. Cell Death Dis. 2017 Dec 13;8(12):3210. doi: 10.1038/s41419-017-0051-2. Cell Death Dis. 2017. PMID: 29238047 Free PMC article.

8

Pathway-based stratification of glioblastoma.

Weiss T, Weller M. Weiss T, et al. Nat Rev Neurol. 2021 May;17(5):263-264. doi: 10.1038/s41582-021-00474-z. Nat Rev Neurol. 2021. PMID: 33654311 No abstract available.

9

A tumor-promoting role for soluble TβRIII in glioblastoma.

Burghardt I, Schroeder JJ, Weiss T, Gramatzki D, Weller M. Burghardt I, et al. Among authors: weiss t. Mol Cell Biochem. 2021 Aug;476(8):2963-2973. doi: 10.1007/s11010-021-04128-y. Epub 2021 Mar 26. Mol Cell Biochem. 2021. PMID: 33772427 Free PMC article.

10

Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21.

Di Nitto C, Neri D, Weiss T, Weller M, De Luca R. Di Nitto C, et al. Among authors: weiss t. Antibodies (Basel). 2022 Mar 4;11(1):19. doi: 10.3390/antib11010019. Antibodies (Basel). 2022. PMID: 35323193 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,505 results

Search Page

Filters